A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
An open-label, single-arm, multicenter, Phase Ib clinical trial to evaluate the efficacy and
safety of CT041 Autologous CAR T Cell Injection after adjuvant chemotherapy in subjects with
pancreatic cancer.